Evommune (EVMN) Capital Leases (2024 - 2026)

Evommune (EVMN) has 3 years of Capital Leases data on file, last reported at $529000.0 in Q1 2026.

• Quarterly Capital Leases changed N/A year-over-year to $529000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $529000.0 (changed N/A YoY) and the FY2025 annual result came in at $181000.0, down 66.17% from the prior year.
• Capital Leases climbed to $529000.0 in Q1 2026 per EVMN's latest filing, from $181000.0 in the prior quarter.
• Across five years, Capital Leases topped out at $535000.0 in Q4 2024 and bottomed at $181000.0 in Q4 2025.
• The 3-year median for Capital Leases is $529000.0 (2026), against an average of $415000.0.
• Peak annual rise in Capital Leases reached 66.17% in 2025, while the deepest fall reached 66.17% in 2025.
• Tracing EVMN's Capital Leases over 3 years: stood at $535000.0 in 2024, then slumped by 66.17% to $181000.0 in 2025, then soared by 192.27% to $529000.0 in 2026.
• Per Business Quant, the three latest EVMN Capital Leases figures stand at $529000.0 (Q1 2026), $181000.0 (Q4 2025), and $535000.0 (Q4 2024).

Peer Comparison